← Back to patent-cliff list
Sevelamer Carbonate
Tier C — Watch / tradeSevelamer Carbonate
Genzyme Corporation
Originator
2000
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Phosphates
Brand：Renvela, Renvela/Renagel
Indications (approved)：Hyperphosphataemia
Regional status
US
Withdrawn
EU
Approved
2000-01-28
China
Approved
2013-06-03
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Sevelamer Carbonate?
Approved indications include: Hyperphosphataemia.
When does the Sevelamer Carbonate patent expire?
No public expiry year is available for Sevelamer Carbonate yet; this page updates once verified.
How do I get a quote for Sevelamer Carbonate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27